A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO). 7. Juni 2016 Sehouli, J., Tomè, O., Dimitrova, D., Camara, O., Runnebaum, I.B., Tessen, H.W., Rautenberg, B., Chekerov, R., Muallem, M.Z., Lux, M.P., Trarbach, T., Gitsch, G., 2016. J. Cancer Res. Clin. Oncol. 143(3), 541–550. doi:10.1007/s00432-016-2307-0 Abstract Dermatux: Phase IV trial of C-FOLFIRI in 1st-line metastatic colorectal cancer receiving a pre-defined skin care. Schimanski, C.C., Staib, F., Goehler, T., Hebart, H.F., Neise, M., Rudi, J., Geer, T., Ehscheidt, P., Flohr, T., Schmittel, A.H., Galle, P.R., Moehler, M.H., 2016. Weiterlesen The PAZOREAL Non-Interventional Study to Assess Effectiveness and Safety of Pazopanib and Everolimus in the Changing Metastatic Renal Cell Carcinoma Treatment Landscape. Goebell, P., Doehn, C., Grüllich, C., Steiner, T., Ehneß, R., Welslau, M., 2016. Ann Oncol 27(suppl_6), 852P. doi:10.1093/annonc/mdw373 Abstract… Weiterlesen